One Shot, Nearly a Year of Lower Lp(a): My Honest Read of the Kylo-11 Lancet Study

A physician's close read of the first-in-human Kylo-11 trial in The Lancet: one siRNA shot lowered Lp(a) by about 53 to 97% at 48 weeks. What excites me, where I pump the brakes, and why it is worth asking for the Lp(a) lab.